Showing results (141-150 of 214) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|February 16, 2024
Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccinationMelissa C Kapulu, Esther Muthumbi, Edward Otieno, et al.
Viruses|September 27, 2025
Assessing the Impact of SARS-CoV-2 Spike Mutations on Antibody Binding: A Comparative Assessment of the Wuhan and JN.1 Variants' Full-Length Spikes in a Multiplex Luminex AssayGerald Waweru, Ruth Nyakundi, Bernadette Kutima, et al.
Lancet (London, England)|April 20, 2019
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance studyLaura L Hammitt, Anthony O Etyang, Susan C Morpeth, et al.
Nature Communications|March 11, 2018
Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4James J Gilchrist, Anna Rautanen, Benjamin P Fairfax, et al.
BMJ Global Health|August 1, 2022
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in KenyaStacey Orangi, John Ojal, Samuel Pc Brand, et al.
Wellcome Open Research|December 14, 2022
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test dataJohn Ojal, Samuel P C Brand, Vincent Were, et al.
Science Advances|March 28, 2017
Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsisLiuyang Wang, Emily R Ko, James J Gilchrist, et al.
The New England Journal of Medicine|May 3, 2014
Diagnosis of childhood tuberculosis and host RNA expression in AfricaSuzanne T Anderson, Myrsini Kaforou, Andrew J Brent, et al.
Plos One|October 29, 2015
Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in KenyaDeron C Burton, Godfrey M Bigogo, Allan O Audi, et al.
BMC Infectious Diseases|December 28, 2024
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in KenyaDoreen Lugano, Bernadette Kutima, Makobu Kimani, et al.
Pageof 22